|Mr. Juan López-Belmonte López||Chairman & Chief Exec. Mang.||150k||N/A||N/A|
|Mr. Juan López-Belmonte Encina||Chief Exec. Mang. & Director||521k||N/A||N/A|
|Mr. Iván López-Belmonte Encina||First VP||412k||N/A||N/A|
|Mr. Javier López-Belmonte Encina||Second VP & CFO||400k||N/A||N/A|
|Mr. Fernando Martínez Morales||Director of Sales||N/A||N/A||N/A|
Laboratorios Farmaceuticos Rovi, S.A. produces and sells pharmaceutical products in Spain and internationally. The companys principal product is Bemiparin, a low molecular weight heparin. Its prescription products comprise Hibor to prevent thromboembolic disease; Osseor to treat osteoporosis; Hepadren to prevent clotting in the extracorporeal circuit; Hirobriz and Ulunar Breezhaler for chronic obstructive pulmonary disease; Medicebran and Medikinet for attention deficit and hyperactivity disorder in children and teenagers; Glufan for relieving symptoms of degenerative osteoarthritis (OA); and Corlentor for coronary artery disease and chronic heart failure. The companys prescription products also include Exxiv for the symptoms of OA, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis; Calcio y Vitamina D3 ROVI for osteoporosis; Bertanel for adults active rheumatoid, juvenile idiopatic, and psoriatic arthritis; Vytorin, Orvatez, and Absorcol for hypercholesterolaemia; Siklos for the prevention of recurrent and painful vaso-occlusive crises; Thymanax for depressive episodes in adults; and Volutsa to treat benign prostatic hyperplasia. In addition, it offers diagnostic products, such as SonoVue for use in ultrasound imaging; Iopamiro and Iomeron radiographic contrast media for diagnosis; and Multihance and Prohance for use in diagnostic magnetic resonance imaging. Further, the company provides OTC products comprising Perspirex to control sweating from the underarms; Enerzona, a protein product; Dentimelo to repair oral mucosal lesions and gums; ColdPack cold and hot bag for reliving pain; and Nitview Ledcomb, a product for lice and nits. Additionally, it distributes products licensed from other laboratories. The company was founded in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Laboratorios Farmaceuticos ROVI, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.